86 related articles for article (PubMed ID: 18623929)
21. Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity.
Bonci D; Musumeci M; Coppola V; Addario A; Conticello C; Hahne M; Gulisano M; Grignani F; De Maria R
Haematologica; 2008 Dec; 93(12):1899-902. PubMed ID: 18838478
[TBL] [Abstract][Full Text] [Related]
22. [Acute myeloblastic leukemia in a 3-month-old infant].
KARNATSEVICH SI
Pediatriia; 1955; 2():82-3. PubMed ID: 14394785
[No Abstract] [Full Text] [Related]
23. Synergistic induction of gene expression during the differentiation into mature macrophage in human myeloblastic leukemia cells treated with TPA and KH1060.
Shimizu T; Kuromi A; Takeda K
Leuk Res; 2009 Jun; 33(6):803-9. PubMed ID: 19144406
[TBL] [Abstract][Full Text] [Related]
24. Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration.
Qiu H; Xue Y; Zhang J; Pan J; Dai H; Wu Y; Wang Y; Chen S; Wu D
Exp Hematol; 2008 Nov; 36(11):1487-95. PubMed ID: 18715689
[TBL] [Abstract][Full Text] [Related]
25. [Interferon production in patients with internal diseases].
Solov'ev VD; Shul'tsev GP; Fedorova IuB; Bektemirov TA; Dibizheva GV; Morozova VT
Klin Med (Mosk); 1969 Aug; 47(8):16-8. PubMed ID: 5309159
[No Abstract] [Full Text] [Related]
26. [Acute myeloblastic leukemia in a 2-month-old infant].
DERZHAVETS FZ; DOMBROVSKAIA EA
Pediatriia; 1953; 4():66-70. PubMed ID: 13088232
[No Abstract] [Full Text] [Related]
27. [Experimental studies of the etiopathogenesis of human leukemia. XVIII. Acute myeloblastic leukemia induced by inoculation of dried blood (36 days) from a patient of chronic myelogenic leukemia of slow and apyretic evolution].
MAS Y MAGRO F
Arch Med Exp; 1955; 18(4):431-6. PubMed ID: 13373564
[No Abstract] [Full Text] [Related]
28. Rabbit anti T-lymphocyte globulin induces apoptosis in peripheral blood mononuclear cell compartments and leukemia cells, while hematopoetic stem cells are apoptosis resistant.
Grüllich C; Ziegler C; Finke J
Biol Blood Marrow Transplant; 2009 Feb; 15(2):173-82. PubMed ID: 19167677
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the interferon regulatory factor 3-mediated antiviral response in a cell line deficient for IFN production.
Chew T; Noyce R; Collins SE; Hancock MH; Mossman KL
Mol Immunol; 2009 Jan; 46(3):393-9. PubMed ID: 19038458
[TBL] [Abstract][Full Text] [Related]
30. Ligand-induced Flt3-downregulation modulates cell death associated proteins and enhances chemosensitivity to idarubicin in THP-1 acute myeloid leukemia cells.
Oveland E; Gjertsen BT; Wergeland L; Selheim F; Fladmark KE; Hovland R
Leuk Res; 2009 Feb; 33(2):276-87. PubMed ID: 18691757
[TBL] [Abstract][Full Text] [Related]
31. Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome.
Asou H; Matsui H; Ozaki Y; Nagamachi A; Nakamura M; Aki D; Inaba T
Biochem Biophys Res Commun; 2009 May; 383(2):245-51. PubMed ID: 19358830
[TBL] [Abstract][Full Text] [Related]
32. Elastin metabolism is disrupted in patients after allogeneic hematopoietic stem cell transplantation (alloHSCT) for acute and chronic myeloid leukemia.
Helbig G; Krzemień S; Francuz T; Wojnar J; Hołowiecki J
Med Sci Monit; 2008 Nov; 14(11):CR584-8. PubMed ID: 18971876
[TBL] [Abstract][Full Text] [Related]
33. [Abnormal expression of transcription factors LYL1 and LMO2 and interaction between them in myeloid leukemia].
Meng YS; Wei R; Ai GW; Meng XQ; Zhang YX
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):890-3. PubMed ID: 19671288
[TBL] [Abstract][Full Text] [Related]
34. Laromustine: the return of alkylators to non-myeloablative therapy of AML.
Giles FJ
Leuk Res; 2009 Aug; 33(8):1022-3. PubMed ID: 19328547
[No Abstract] [Full Text] [Related]
35. Activation of Wnt signalling in acute myeloid leukemia by induction of Frizzled-4.
Tickenbrock L; Hehn S; Sargin B; Choudhary C; Bäumer N; Buerger H; Schulte B; Müller O; Berdel WE; Müller-Tidow C; Serve H
Int J Oncol; 2008 Dec; 33(6):1215-21. PubMed ID: 19020754
[TBL] [Abstract][Full Text] [Related]
36. The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesis.
Birtwistle J; Hayden RE; Khanim FL; Green RM; Pearce C; Davies NJ; Wake N; Schrewe H; Ride JP; Chipman JK; Bunce CM
Mutat Res; 2009 Mar; 662(1-2):67-74. PubMed ID: 19162045
[TBL] [Abstract][Full Text] [Related]
37. A brief history of interferon's trajectory to clinical application, and personal reminiscences of a large-scale human interferon production initiative.
Billiau A
Verh K Acad Geneeskd Belg; 2009; 71(1-2):15-42. PubMed ID: 19739396
[TBL] [Abstract][Full Text] [Related]
38. Tumor-specific cytotoxicity and type of cell death induced by sodium 5,6-benzylidene-L-ascorbate.
Kishino K; Hashimoto K; Amano O; Kochi M; Liu WK; Sakagami H
Anticancer Res; 2008; 28(5A):2577-84. PubMed ID: 19035281
[TBL] [Abstract][Full Text] [Related]
39. Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.
Pigneux A; Mahon FX; Uhalde M; Jeanneteau M; Lacombe F; Milpied N; Reiffers J; Belloc F
Exp Hematol; 2008 Dec; 36(12):1648-59. PubMed ID: 18922616
[TBL] [Abstract][Full Text] [Related]
40. [More about interferon].
Med Monatsschr; 1968 Aug; 22(8):338-9. PubMed ID: 5249081
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
